Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Erasca, Inc. | ERAS | 5.25M | $96.18M |
Roivant Sciences Ltd. | ROIV | 3.75M | $132.71M |
First Tracks Biotherapeutics Inc | TRAX | 2.03M | $40.88M |
Trevi Therapeutics, Inc. | TRVI | 1.8M | $33.57M |
Xenon Pharmaceuticals Inc. | XENE | 1.59M | $96.27M |
Spyre Therapeutics, Inc. | SYRE | 1.28M | $113.56M |
Alkermes plc | ALKS | 1.13M | $58.94M |
Relay Therapeutics, Inc. | RLAY | 1.05M | $19.65M |
Apogee Therapeutics, Inc. | APGE | 987K | $131M |
Nurix Therapeutics, Inc. | NRIX | 967.62K | $23.47M |
Cullinan Therapeutics, Inc. | CGEM | 875.76K | $15.95M |
Jade Biosciences, Inc. | JBIO | 840.35K | $18.67M |
AnaptysBio, Inc. | ANAB | 826.11K | $55.76M |
Odyssey Therapeutics, Inc. | ODTX | 766.35K | $14.34M |
Mineralys Therapeutics, Inc. | MLYS | 750K | $20.23M |
Korro Bio, Inc. | KRRO | 706.9K | $9.32M |
Celldex Therapeutics, Inc. | CLDX | 700K | $26.05M |
Insmed Incorporated | INSM | 650K | $69.3M |
Oruka Therapeutics, Inc. | ORKA | 590K | $56.15M |
Cytokinetics, Incorporated | CYTK | 550K | $46.85M |